Surgical redo versus transseptal or transapical transcatheter mitral valve‐in‐valve implantation for failed mitral valve bioprosthesis
Catheterization and Cardiovascular Interventions2020Vol. 97(4), pp. 714–722
Citations Over TimeTop 10% of 2020 papers
Federico Simonetto, Paola Purita, Massimiliano Malerba, Marco Barbierato, Andrea Pascotto, Domenico Mangino, Chiara Zanchettin, Giuseppe Tarantini, Gino Gerosa, Augusto D’Onofrio, Carlo Cernetti, Luca Favero, Alessandro Daniotti, Giuseppe Minniti, Francesco Caprioglio, G Erente, Tommaso Hinna Danesi, Anna Chiara Frigo, Federico Ronco
Abstract
For the selected patients, TS-TMViV and TA-TMViV are to be considered a valid alternative to redo-SMVR with comparable 1-year survival. TS-TMViV is the less invasive strategy and has the advantage of shortening the LOS compared with TA-TMViV.
Related Papers
- → Mitral Valve Replacement Is a Viable Alternative to Mitral Valve Repair for Ischemic Mitral Regurgitation: A Case-Matched Study(2011)58 cited
- → Systematic Approach to the Calcified Mitral Valve Apparatus at Time of Mitral Valve Replacement(2021)3 cited
- → The MITRIS RESILIA mitral valve is a safe and effective option for mitral valve replacement in young patients requiring mitral valve replacement(2022)3 cited
- → Results of mitral valve repair versus mitral valve replacement for isolated active infective mitral valve endocarditis: 20-year single center experience(2008)
- [The first clinical experience and technical peculiarities of mitral valve homograft implantation].(2002)